Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis
Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis
Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis
Submitted by
admin
on March 20, 2017 - 10:57am
Source:
Fierce Pharma
News Tags:
AstraZeneca
JNJ
Eli Lilly
Boehringer Ingelheim
diabetes
Farixga
Invokana
Jardiance
SGLT2 inhibitor
Headline:
Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis
Do Not Allow Advertisers to Use My Personal information
